Telomerase Gene Therapy

About Telocyte

Telocyte is a private, preclinical-stage biotech targeting a fundamental cure for Alzheimer's disease through telomerase gene therapy. The company, founded by Dr. Michael Fossel, a pioneer in the field, posits that telomere shortening in glial cells triggers the pathological cascade of Alzheimer's, and restoring telomerase activity can reverse this process. While still in the research and development phase, Telocyte plans to initiate human clinical trials to test its hypothesis, positioning itself in the high-risk, high-reward space of disease-modifying Alzheimer's therapies. The company's mission is driven by a personal commitment to move beyond symptomatic treatments to a genuine reversal of the disease.

Therapeutic Areas

Other Alzheimer's Disease Drugs